Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the ...

Sky Germany reports that Mainz are now leading the race ahead of Borussia Mönchengladbach for Montpellier forward Arnaud ...

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements ...

Mainz are closing in on signing Montpellier winger Arnaud Nordin (26), reports Le Parisien. An agreement is reportedly close ...

Luton’s on-loan midfielder Tom Krauß has been linked with a move back to Germany during the transfer window.

After an underwhelming 2023/24 season, Mainz are now in the running for the UEFA Champions League places. So what's clicking ...

Musk's support for AfD has helped what was once a fringe political party enter the mainstream, lifting it up in front of a ...

Mainz Biomed NV (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...

As Germany's parliamentary elections approach, misinformation about migrants and asylum seekers has been circulating widely ...

Manchester City could yet lose midfield talent James McAtee on loan for the remainder of the season amid growing interest ...

The battle at the MEWA Arena promises intrigue as 1. FSV Mainz 05 hosts VfB Stuttgart in what could shape both clubs’ ...

BERKELEY, Calif. and MAINZ, Germany - Mainz Biomed NV (NASDAQ:MYNZ), a company focused on early cancer detection diagnostics, has announced its return to compliance with Nasdaq's stockholders' equity ...